/
BIOA
$24.95+$1.19 (+5.01%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.1B
44M shares
52-week range
$4.07 – $25.80
96% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
0.40%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$6.64
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $9.0M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $9.0M |
| Gross margin | — | — | — | 100.0% |
| R&D | $30.5M | $33.9M | $59.0M | $74.0M |
| Operating income | −$40.0M | −$48.4M | −$78.2M | −$92.8M |
| EBITDA | −$39.4M | −$55.9M | −$68.6M | −$79.7M |
| Net income | −$39.7M | −$63.9M | −$71.1M | −$80.6M |
| Net margin | — | — | — | -896.1% |
| EPS (diluted) | -1.16 | -1.87 | -1.98 | -2.24 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $54M | $-2.56 | $-2.90–$-2.02 | 6 |
| 2027 | $35M | $-1.88 | $-3.25–$1.27 | 6 |
| 2028 | $3M | $-2.73 | $-3.66–$-2.13 | 8 |
| 2029 | $19M | $-2.80 | $-17.73–$0.75 | 6 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$9.27
Price
$24.95
Implied downside
-63%
Peer comparison
BioAge Labs, Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
www.bioagelabs.com- Employees
- 62
- IPO / List date
- Sep 26, 2024
- HQ
- EMERYVILLE, CA
Held by traders on TradeandTell
No one on the platform currently holds BIOA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 138,588 | $2.4M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BIOA yet.
